Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project The ProCAncer-I project has completed the first year of its lifecycle at the end of October 2021. With this brief note key results and achievements of the first year are summarized in the sequel....
Newsletter #2
UC1: Detection of prostate cancer with high accuracy in both the peripheral and transitional zone
Within the ProCancer-I project, a total of nine clinical needs will be addressed utilizing artificial intelligence (AI) models trained on ProstateNET – a unified repository of 1.5 million images of prostate MRI acquired across the consortium. In the current landscape...
(Meta)Data Infrastructure for Trustworthy AI
ProCAncer-I aspires to create the largest interoperable, high-quality multi-parametric Magnetic Resonance Imaging (mpMRI) dataset worldwide/globally comprising more than 11.000 retrospective and more than 6.000 prospective mpMRI examinations, including clinical data,...
The clinical vision and impact of the project
Interview with prof. Daniele Regge (Clinical Coordinator of the ProCancer-I project) Q: In the case of prostate cancer there are several tests that can help clinicians in the decision process, for example, prediction algorithms based on PSA blood test and biopsy. Why...
A regulated pathway for Artificial Intelligence in Medical Imaging
A brief historical survey of European state-of-play, the open issues and the ProCAncer-I approach Over the last decade, Artificial Intelligence (AI) solutions to support the whole value-chain of medical imaging[1] has experienced a considerable acceleration. This...
Presentation of partner Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF)
By the Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF) Champalimaud Foundation (CF) is a private non-profit Portuguese institution, inaugurated in 2010 with the aim of advancing basic and translational world-leading research in...
Presentation of partner FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE)
By the FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE) The FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE) is a Spanish non-profit organization that carries out...
Presentation of partner Massachusetts General Hospital (The General Hospital Corp) (QTIM)
By the Massachusetts General Hospital (The General Hospital Corp) (QTIM) Our lab, the Quantitative Translational Imaging in Medicine (QTIM) lab, at the Athinoula A. Martinos Center for Biomedical Imaging of the Massachusetts General Hospital (MGH), focuses on...
Newsletter #2 Contents
Highlights
ProCAncer-I at the ECR 2024 in Vienna
Mar 12, 2024
A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...
Gold medal from the European Society of Radiology to Prof. Dr. Deniz Akata
Mar 4, 2024
Hacettepe University Department of Radiology Faculty Member Prof. Dr. Deniz Akata was awarded the ESR Gold Medal by the European Society of Radiology for her contributions to the field of radiology and European radiology. Prof. Dr. Deniz Akata is the first Turkish...
Exploring the Intersection of mpMRI and Digital Histopathology in Prostate Cancer Management: Opportunities and Challenges
Feb 22, 2024
Nikolaos Papanikolaou, Ph.D. In the realm of prostate cancer diagnosis and management, multiparametric magnetic resonance imaging (mpMRI) and digital histopathology stand as pivotal technologies. Each brings unique capabilities to the table, yet their comparison...
ProCAncer-I at the ECR 2024 in Vienna
Feb 20, 2024
We are really happy to announce that we will be present at the ECR Congress in Vienna from February 28 to March 3,2024. During the congress,. ProCAncer-I project, along with CHAIMELEON, EuCanImage, INCISIVE and EUCAIM will hold a presentation on "Artificial...